Journal of Cancer Research and Therapeutics Close
 

Figure 3: Abdominal masses computed tomography scans (a and b) Before chemotherapy with 1st gemcitabine and nedaplatin administration (July 13, 2019) (c and d) After 2 cycles of gemcitabine and nedaplatin (October 05, 2019) (e and f) Before VEC and apatinib administration (November 21, 2019) (g and h) After 2 cycles of VEC and apatinib (January 17, 2020) (i and j) After 4 cycles of VEC and apatinib (April 20, 2020) (k and l) After 6 cycles of VEC and apatinib (July 30, 2020)

Figure 3: Abdominal masses computed tomography scans (a and b) Before chemotherapy with 1<sup>st</sup> gemcitabine and nedaplatin administration (July 13, 2019) (c and d) After 2 cycles of gemcitabine and nedaplatin (October 05, 2019) (e and f) Before VEC and apatinib administration (November 21, 2019) (g and h) After 2 cycles of VEC and apatinib (January 17, 2020) (i and j) After 4 cycles of VEC and apatinib (April 20, 2020) (k and l) After 6 cycles of VEC and apatinib (July 30, 2020)